UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

June 19, 2006

CURON MEDICAL, INC.

(Exact name of registrant as specified in its charter)

Delaware

000-31519

77-0470324

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

46117 Landing Parkway

Fremont, California 94538

(Address of principal executive offices, including zip code)

(510) 661-1800

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 4.01. Changes In Registrant’s Certifying Accountant.

(b) Curon Medical, Inc. has engaged Stonefield Josephson, Inc. as its independent registered public accounting firm to audit the Company’s financial statements as of and for the year ending December 31, 2006. The engagement is effective as of June 19, 2006.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


CURON MEDICAL, INC.

By:		/s/ Larry C. Heaton II
		Larry C. Heaton II President, Chief Executive Officer

Date: June 22, 2006

CURON MEDICAL INC 8-K